Phosplatin Therapeutics Inc. announced it raised $37.3 Million in an initial filing from an offering of $37.3 Million
Phosplatin Therapeutics Inc. announced it raised $37.3 Million in an initial filing from an offering of $37.3 Million
12/15/21, 4:58 PM
Location
Money raised
$37.3 million
Industry
healthcare
Company Info
Location
1350 avenue of the americas
new york, new york, united states
Additional Info
Phosplatin is addressing unmet needs in the era of oncology immunotherapy
by developing novel small molecule anti-cancer agents. Our lead agent,
PT-112, represents the best-in-class immunogenic cell death (ICD) inducer.